Sept. 5, 2018 Our microbiome includes all of the trillions of microorganisms that live in and on us. A recent review article about key discoveries on the role of the microbiome in lupus includes two researchers funded by the Lupus Research Alliance who may have discovered how some of these microbial passengers promote lupus by […] READ MORE
August 28, 2018 NEW YORK, NY. Aker BioMarine and Lupus Research Alliance launch a new clinical study, investigating how phospholipid-rich krill oil can benefit people with lupus, with the aim to lessen the severity of symptoms associated with the disease. Affecting an estimated 5 million people worldwide, Systemic Lupus Erythematosus (SLE), better known as lupus, […] READ MORE
July 26, 2018 By uncovering how some killer viruses beat our immune system, scientists partly funded by the Lupus Research Alliance have identified a potential new way to treat lupus. The viruses that cause Lassa fever and other similar diseases kill thousands of people every year. One reason these viruses are deadly is that they […] READ MORE
July 3, 2018 Neovacs announced the results of its Phase IIb clinical trial of the investigational agent IFNalpha Kinoid in patients with moderate to severe lupus (SLE). The results show that IFNalpha Kinoid very significantly reduced the levels of type I interferon genes in the blood and tissue cells of people with lupus. High levels […] READ MORE
June 5, 2018 The Lupus Research Alliance is driven by one central goal — to improve the lives of people living with the disease, today and in the long term. We believe that scientific research is the most powerful way we can achieve this goal. Further, we believe that by both pushing the limits of scientific exploration and […] READ MORE
April 24, 2018 Scientists funded by the Lupus Research Alliance may have discovered why patients with lupus are at risk for heart disease. Most recently, at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Dr. Mariana Kaplan and colleagues found that abnormal immune system cells are damaging patients’ arteries. Published in the journal […] READ MORE
April 20, 2018 The Lupus Research Alliance Lupus Industry Council (LIC) met a key objective with the recent publication in the medical journal Arthritis & Rheumatology reporting on a new tool to better measure the effectiveness of potential drug treatments in clinical trials. The LIC aims to bring industry and academia together to work collaboratively, […] READ MORE
April 18, 2018 A new study by Lupus Research Alliance-funded researcher Dr. Matthew Weirauch of the Cincinnati Children’s Hospital Medical Center in Ohio and colleagues might explain how a common virus that causes mononucleosis also boosts the risk for lupus. The virus may be turning on human genes that promote the illness. The scientists, including […] READ MORE
April 11, 2018 Nine Outstanding Investigators Receive Funding for Innovative Research on Lupus Causes, Pathways, and New Treatment Development Today, the Lupus Research Alliance announced nine new Novel Research Grants to support paradigm-changing lupus research. To conquer the complexity of lupus, the Novel Research Grants explore lupus from many perspectives, testing new theories about what […] READ MORE
April 5, 2018 A new clinical study published in the prestigious medical journal The Lancet found that sirolimus, a drug currently FDA approved to prevent organ transplant rejection, may offer a safe and effective treatment for lupus. In an accompanying editorial, Lupus Research Alliance Scientific Advisory Board Co-Chair Mary Crow, MD notes that in addition […] READ MORE
April 5, 2018 Congratulations go to Dr. Zhijian ‘James’ Chen — just named the 2018 Lurie Prize in Biomedical Sciences recipient by the Foundation for the National Institutes of Health. The highly prestigious award recognizes Dr. Chen’s exceptional work that the Lupus Research Alliance proudly helped fund. His discovery of an enzyme cGAS uncovered an […] READ MORE
March 12, 2018 Bacteria Could be to Blame for Autoimmune Attacks Innovative novel research, co-funded by the Lupus Research Alliance, has produced a significant discovery about the role of bacteria and points to the potential for a vaccine or treatment that might prevent an autoimmune attack by suppressing specific bacteria. Led by Dr. Martin Kriegel […] READ MORE
